外周静脉置入中心静脉导管与植入式静脉输液港在乳腺癌化疗中应用.docVIP

外周静脉置入中心静脉导管与植入式静脉输液港在乳腺癌化疗中应用 　　[摘要] 目的 通过对外周静脉置入中心静脉导管（PICC）与植入式静脉输液港（TIVAP）在乳腺癌化疗的应用比较，为乳腺癌化疗选择理想深静脉通道提供科学依据。 方法 收集2008年7月～2012年1月于珠海市妇幼保健院诊治的乳腺癌患者244例，按照置管方式分为PICC组（139例）及TIVAP组（105例）。对两组患者在置管操作时间、置管长度、置管成功率、置管并发症发生率等各方面进行对比分析。 结果 PICC组置管操作时间[（12.63±8.03）min]明显少于TIVAP组[（33.84±11.74）min]，PICC组置管长度[（42.85±2.48）cm]长于TIVAP组[（11.76±0.70）cm]，差异均有高度统计学意义（P 0.05）。PICC组的导管异位发生率（9.35%）、静脉炎发生率（9.35%）及导管堵塞发生率（4.32%）均高于TIVAP组（均为0.00%），差异均有统计学意义（P 0.05）；TIVAP组总并发症发生率（9.52%）低于PICC组总并发症发生率（35.97%），差异有高度统计学意义（P 0.01）。 结论 TIVAP比PICC并发症发生率低，更加安全、可靠，可作为乳腺癌化疗理想深静脉通道。 　　[关键词] 外周静脉置入中心静脉导管；植入式静脉输液港；乳腺肿瘤 　　[中图分类号] R73 [文献标识码] A [文章编号] 1673-7210（2014）10（b）-0047-05 　　Comparison of peripherally inserted central catheter and totally implantable venous access port in chemotherapy of breast cancer 　　ZHENG Mingkang1 CHEN Hui2 　　1.Department of General Surgery， Maternity and Child Health Hospital of Zhuhai City， Guangdong Province， Zhuhai 519000， China； 2.Department of Maternal and Child Health Care， Tongji College of Medical， Huazhong University of Science and Technology， Hubei Province， Wuhan 430030， China. 　　[Abstract] Objective To compare peripherally inserted central catheter （PICC） and totally implantable venous access port （TIVAP） in chemotherapy of breast cancer， and provide scientific basis for choosing ideal deep venous channel. Methods From July 2008 to January 2012， in Maternity and Child Health Hospital of Zhuhai City， 244 patients with breast cancer were enrolled and divided into two groups： PICC group （139 cases） and TIVAP group （105 cases）. Operating time， catheter length， success rate and incidence rate of complication were compared between the two groups. Results The average operating time [（12.63±8.03） min] of were shorter than that of TIVAP group [（33.84±11.74） min]， and the average catheter length [（42.85±2.48） cm] of PICC group were longer than that of TIVAP group [（11.76±0.70） cm] in and， the differences were statistically significant （P 0.05）. The incidence